Jane Street’s Caris Life Sciences CAI Stock Holding History

Jane Street’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$869K	Buy	48,600 +19,000	+64%	+$415K	﹤0.01%	6823
2025 Q4	$799K	Sell	29,600 -3,100	-9%	-$87.3K	﹤0.01%	6617
2025 Q3	$989K	Buy	+32,700	New	+$1.04M	﹤0.01%	6331

Other funds holding CAI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM

SSP

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jane Street's CAI Position: Q1 2026 in Review

Jane Street sold out of Caris Life Sciences (CAI) in Q1 2026, closing a stake of 170,997 shares — an estimated $3.74M sold.

Jane Street first reported a position in CAI in Q3 2025 and held it in 2 quarters. The position peaked at $4.61M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

Jane Street reported no remaining Caris Life Sciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 170,997 Caris Life Sciences shares in Q1 2026, an estimated $3.74M.
Jane Street first reported a position in Caris Life Sciences in Q3 2025 and held it in 2 quarters.
Jane Street's Caris Life Sciences position peaked at $4.61M in Q4 2025.
202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.